A Philadelphia jury sent a strong message to Johnson & Johnson regarding the company's marketing of its prescription drug Risperdal. A Maryland man filed a lawsuit alleging that the company failed to properly acknowledge known risks that the prescription medication could lead to breast growth in boys.
Fourteen years after the State of Texas recovered $17.3 billion from tobacco manufacturers, Texas Attorney General Greg Abbott now returns to the courtroom this week against pharmaceutical giant, Janssen Pharmaceutical LLC in hopes to recover more than $1 billion in damages. Abbott is charging Johnson & Johnson Inc., its wholly owned subsidiary Janssen, and five other related companies for implementing a "sophisticated marketing scheme" to defraud the state into overpaying for Janssen's schizophrenia drug, Risperdal. The state also alleges in its lawsuit that the pharmaceutical companies misled Texas health officials about Risperdal's effectiveness, risk of side effects, and safety for pediatric use.